ZA909302B - Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses - Google Patents
Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retrovirusesInfo
- Publication number
- ZA909302B ZA909302B ZA909302A ZA909302A ZA909302B ZA 909302 B ZA909302 B ZA 909302B ZA 909302 A ZA909302 A ZA 909302A ZA 909302 A ZA909302 A ZA 909302A ZA 909302 B ZA909302 B ZA 909302B
- Authority
- ZA
- South Africa
- Prior art keywords
- immunogens
- prophylaxis
- against human
- viral agents
- retroviral particles
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- 239000002245 particle Substances 0.000 title 1
- 238000011321 prophylaxis Methods 0.000 title 1
- 230000001177 retroviral effect Effects 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 241001430294 unidentified retrovirus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43920589A | 1989-11-20 | 1989-11-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA909302B true ZA909302B (en) | 1991-09-25 |
Family
ID=23743729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA909302A ZA909302B (en) | 1989-11-20 | 1990-11-20 | Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0502105A4 (en) |
| JP (1) | JPH05503629A (en) |
| KR (1) | KR920703639A (en) |
| AU (1) | AU636944B2 (en) |
| CA (1) | CA2068713A1 (en) |
| ES (1) | ES2052478T1 (en) |
| FI (1) | FI922277A (en) |
| GR (1) | GR930300005T1 (en) |
| HU (1) | HUT60506A (en) |
| NO (1) | NO921969L (en) |
| OA (1) | OA09698A (en) |
| TW (1) | TW216446B (en) |
| WO (1) | WO1991007425A1 (en) |
| ZA (1) | ZA909302B (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1990015141A2 (en) * | 1989-06-01 | 1990-12-13 | Applied Biotechnology, Inc. | Self-assembled, defective, non-self-propagating viral particles |
| US5861282A (en) * | 1989-10-16 | 1999-01-19 | Whitehead Institute For Biomedical Research | Non-infectious HIV particles and uses therefor |
| WO1991019803A1 (en) * | 1990-06-19 | 1991-12-26 | Applied Biotechnology, Incorporated | Self assembled, defective, nonself-propagating viral particles |
| DE4124817A1 (en) * | 1991-07-26 | 1993-01-28 | Basf Ag | AQUEOUS POLYMER DISPERSIONS |
| CA2120137C (en) * | 1991-11-08 | 2004-05-04 | The Upjohn Company | Feline leukemia virus vaccines |
| WO1993020840A1 (en) * | 1992-04-14 | 1993-10-28 | British Bio-Technology Limited | Induction of ctl responses |
| ATE302854T1 (en) | 1993-01-26 | 2005-09-15 | Univ Pennsylvania | COMPOSITIONS AND METHODS FOR ADMINISTRATION OF GENETIC MATERIAL |
| EP1770168A3 (en) * | 1993-01-26 | 2009-05-06 | The Trustees of the University of Pennsylvania (a corporation of Pennsylvania) | Compositions and methods for delivery of genetic material |
| US7001759B1 (en) | 1993-01-26 | 2006-02-21 | The Trustees Of The University Of Pennsylvania | Compositions and methods for delivery of genetic material |
| GB9304239D0 (en) * | 1993-03-01 | 1993-04-21 | British Bio Technology | Viral particles |
| US5858838A (en) | 1998-02-23 | 1999-01-12 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method for increasing DRAM capacitance via use of a roughened surface bottom capacitor plate |
| US5955342A (en) * | 1994-08-15 | 1999-09-21 | Connaught Laboratories Limited | Non-infectious, replication-defective, self-assembling HIV-1 viral particles containing antigenic markers in the gag coding region |
| US6291157B1 (en) | 1998-02-23 | 2001-09-18 | Connaught Laboratories Limited | Antigenically-marked non-infectious retrovirus-like particles |
| US6080408A (en) | 1994-08-22 | 2000-06-27 | Connaught Laboratories Limited | Human immunodeficiency virus type 1 nucleic acids devoid of long terminal repeats capable of encoding for non-infectious, immunogenic, retrovirus-like particles |
| EP0817854A2 (en) * | 1995-03-31 | 1998-01-14 | Wolf, Hans, Prof. Dr. | Antigen presentation system based on retrovirus-like particles |
| US6013506A (en) * | 1995-06-05 | 2000-01-11 | Wardley; Richard C. | Feline leukemia virus vaccines |
| US6121021A (en) * | 1997-12-16 | 2000-09-19 | Connaught Laboratories Limited | Constitutive expression of non-infectious HIV-like particles |
| EP1141314A2 (en) | 1998-12-31 | 2001-10-10 | Chiron Corporation | Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| ATE384795T1 (en) | 1998-12-31 | 2008-02-15 | Novartis Vaccines & Diagnostic | MODIFIED HIV ENV POLYPEPTIDES |
| CA2401974C (en) | 2000-03-02 | 2013-07-02 | Emory University | Dna expression vectors and methods of use |
| WO2002072754A2 (en) | 2001-03-08 | 2002-09-19 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Mva expressing modified hiv envelope, gag, and pol genes |
| US8623379B2 (en) | 2000-03-02 | 2014-01-07 | Emory University | Compositions and methods for generating an immune response |
| JP5033303B2 (en) | 2001-07-05 | 2012-09-26 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | Polynucleotides encoding polypeptides with antigenic type C HIV, polypeptides and uses thereof |
| US20030170614A1 (en) | 2001-08-31 | 2003-09-11 | Megede Jan Zur | Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| WO2012137071A2 (en) | 2011-04-06 | 2012-10-11 | Biovaxim Limited | Pharmaceutical compositions for preventing and/or treating an hiv disease in humans |
| WO2017015463A2 (en) | 2015-07-21 | 2017-01-26 | Modernatx, Inc. | Infectious disease vaccines |
| US11045540B2 (en) | 2017-03-15 | 2021-06-29 | Modernatx, Inc. | Varicella zoster virus (VZV) vaccine |
| WO2018170256A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Herpes simplex virus vaccine |
| US20220241399A1 (en) * | 2019-03-15 | 2022-08-04 | Moderna TX, Inc. | Hiv rna vaccines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4752565A (en) * | 1986-04-07 | 1988-06-21 | The United States Of America As Represented By The Department Of Health And Human Services | Cell line producing AIDS viral antigens without producing infectious virus particles |
| JPH02203783A (en) * | 1989-02-02 | 1990-08-13 | Banyu Pharmaceut Co Ltd | Cloned human t cell forming non-virulent aids virus having antigenicity |
| JP3140757B2 (en) * | 1989-02-06 | 2001-03-05 | デイナ・フアーバー・キヤンサー・インステイテユート | Packaging defective HIV provirus, cell lines and uses thereof |
| GB8923123D0 (en) * | 1989-10-13 | 1989-11-29 | Connaught Lab | A vaccine for human immunodeficiency virus |
| EP0496794A1 (en) * | 1989-10-16 | 1992-08-05 | Whitehead Institute For Biomedical Research | Non-infectious hiv-1 particles and uses therefor |
-
1990
- 1990-11-20 ES ES91900526T patent/ES2052478T1/en active Pending
- 1990-11-20 AU AU69055/91A patent/AU636944B2/en not_active Ceased
- 1990-11-20 EP EP19910900526 patent/EP0502105A4/en not_active Withdrawn
- 1990-11-20 KR KR1019920701189A patent/KR920703639A/en not_active Application Discontinuation
- 1990-11-20 WO PCT/US1990/006798 patent/WO1991007425A1/en not_active Application Discontinuation
- 1990-11-20 HU HU9201659A patent/HUT60506A/en unknown
- 1990-11-20 ZA ZA909302A patent/ZA909302B/en unknown
- 1990-11-20 CA CA002068713A patent/CA2068713A1/en not_active Abandoned
- 1990-11-20 JP JP3501082A patent/JPH05503629A/en active Pending
-
1991
- 1991-01-12 TW TW080100246A patent/TW216446B/zh active
-
1992
- 1992-05-19 FI FI922277A patent/FI922277A/en not_active Application Discontinuation
- 1992-05-19 OA OA60209A patent/OA09698A/en unknown
- 1992-05-19 NO NO92921969A patent/NO921969L/en unknown
-
1993
- 1993-04-28 GR GR930300005T patent/GR930300005T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU636944B2 (en) | 1993-05-13 |
| GR930300005T1 (en) | 1993-04-28 |
| CA2068713A1 (en) | 1991-05-21 |
| NO921969L (en) | 1992-06-26 |
| AU6905591A (en) | 1991-06-13 |
| HU9201659D0 (en) | 1992-08-28 |
| TW216446B (en) | 1993-11-21 |
| HUT60506A (en) | 1992-09-28 |
| EP0502105A4 (en) | 1993-02-24 |
| ES2052478T1 (en) | 1994-07-16 |
| KR920703639A (en) | 1992-12-18 |
| JPH05503629A (en) | 1993-06-17 |
| FI922277A0 (en) | 1992-05-19 |
| NO921969D0 (en) | 1992-05-19 |
| FI922277A (en) | 1992-05-19 |
| WO1991007425A1 (en) | 1991-05-30 |
| OA09698A (en) | 1993-08-30 |
| EP0502105A1 (en) | 1992-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA909302B (en) | Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses | |
| GB2204237B (en) | Agents for the prophylaxis and therapy of retroviral infections | |
| EP0491861A4 (en) | Prophylaxis and therapy of acquired immunodeficiency syndrome | |
| EP0330496A3 (en) | Skin treatment composition | |
| GB8807246D0 (en) | Therapeutic agents | |
| RU1833139C (en) | Acaricidic agent in the form of emulsifiable concentrate | |
| IL96404A0 (en) | Nonreplicating recombinant-made retroviral particles useful as anti-viral agents and as immunogens for prophylaxis and therapy against human retroviruses | |
| GB2236675B (en) | Cosmetic weight reduction treatment | |
| GB2203645B (en) | Improvements in the treatment of hair | |
| GB8812596D0 (en) | Therapeutic agents | |
| GB8804531D0 (en) | Skin treatment formulations | |
| ZA891894B (en) | Composition for the treatment of osteoporosis in humans | |
| GB8804016D0 (en) | Therapeutic agents | |
| GB2220652B (en) | Treatment of pastures | |
| GB8918242D0 (en) | Preparation of agents for use in therapy | |
| ZA882667B (en) | Agents for the prophylaxis and therapy of retroviral infections | |
| ZA897549B (en) | Medicament for the treatment of diseases caused by retroviruses | |
| GB8801759D0 (en) | Therapeutic agents | |
| GB8801758D0 (en) | Therapeutic agents | |
| GB8812145D0 (en) | Therapeutic agents | |
| GB2208599B (en) | Oral anti-malarial treatment | |
| SG4695G (en) | Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases | |
| GB8818556D0 (en) | Novel therapeutic immunoconjugates for use in treatment of cancer | |
| GB8827618D0 (en) | Treatments of immunodeficiency | |
| CS732089A3 (en) | Preparation for hair final treatment |